Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.21.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 9,627 $ 10,800
Premium and trade receivables 11,601 9,696
Short-term investments 1,662 1,580
Other current assets 1,550 1,317
Total current assets 24,440 23,393
Long-term investments 13,245 12,853
Restricted deposits 1,113 1,060
Property, software and equipment, net 2,822 2,774
Goodwill 18,788 18,652
Intangible assets, net 8,235 8,388
Other long-term assets 1,642 1,599
Total assets 70,285 68,719
Current liabilities:    
Medical claims liability 12,842 12,438
Accounts payable and accrued expenses 6,866 7,069
Return of premium payable 1,935 1,458
Unearned revenue 574 523
Current portion of long-term debt 62 97
Total current liabilities 22,279 21,585
Long-term debt 16,695 16,682
Deferred tax liability 1,641 1,534
Other long-term liabilities 3,134 2,956
Total liabilities 43,749 42,757
Commitments and contingencies
Redeemable noncontrolling interests 78 77
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2021 and December 31, 2020 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 599,608 issued and 582,682 outstanding at March 31, 2021, and 598,249 issued and 581,479 outstanding at December 31, 2020 1 1
Additional paid-in capital 19,500 19,459
Accumulated other comprehensive earnings 176 337
Retained earnings 7,491 6,792
Treasury stock, at cost (16,926 and 16,770 shares, respectively) (826) (816)
Total Centene stockholders’ equity 26,342 25,773
Nonredeemable noncontrolling interest 116 112
Total stockholders’ equity 26,458 25,885
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 70,285 $ 68,719